Lista de obras - Peter Klivenyi - Dominio Público Uruguay

24-Hour Near-Infrared Spectroscopy Monitoring of Acute Ischaemic Stroke Patients Undergoing Thrombolysis or Thrombectomy: A Pilot Study

artículo científico publicado en 2019

A new myelin protein, TPPP/p25, reduced in demyelinated lesions is enriched in cerebrospinal fluid of multiple sclerosis

artículo científico publicado en 2011

A novel SETX gene mutation producing ataxia with oculomotor apraxia type 2.

artículo científico publicado en 2016

Additive neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.

artículo científico publicado en 2003

Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis

artículo científico publicado en 2004

Alpha-tocopherol and NADPH in the erythrocytes and plasma of multiple sclerosis patients. Effect of interferon-beta-1b treatment

artículo científico publicado en 2003

Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines.

artículo científico publicado en 2018

Amino acid concentrations in cerebrospinal fluid of patients with multiple sclerosis

artículo científico publicado en 1997

Amino acids in the saliva of patients with migraine

scientific article published on 01 October 1999

An assessment of the frequency of mutations in the GBA and VPS35 genes in Hungarian patients with sporadic Parkinson’s disease

article

Angiogenin mutations in Hungarian patients with amyotrophic lateral sclerosis: Clinical, genetic, computational, and functional analyses.

artículo científico publicado en 2019

Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients

artículo científico publicado en 2019

Assessment of the role of multidrug resistance-associated proteins in MPTP neurotoxicity in mice

artículo científico publicado en 2013

Association of vitamin D receptor gene polymorphisms and Parkinson's disease in Hungarians.

artículo científico publicado en 2013

Azulenyl nitrone spin traps protect against MPTP neurotoxicity.

artículo científico publicado en 1998

B7 costimulation and intracellular indoleamine-2,3-dioxygenase (IDO) expression in peripheral blood of healthy pregnant and non-pregnant women.

artículo científico publicado en 2014

Behaviour changes in a transgenic model of Huntington's disease.

artículo científico publicado en 2006

Central nervous system-specific alterations in the tryptophan metabolism in the 3-nitropropionic acid model of Huntington's disease

artículo científico publicado en 2015

Clinical studies on pramipexol retard

artículo científico publicado en 2010

Clinical studies with levodopa/carbidopa intestinal gel

artículo científico publicado en 2014

Clinicopathological Relationships in an Aged Case of DOORS Syndrome With a p.Arg506X Mutation in the ATP6V1B2 Gene

artículo científico publicado en 2020

Cognitive functions in ataxia with oculomotor apraxia type 2.

artículo científico publicado en 2012

Different phenotypes in identical twins with cerebrotendinous xanthomatosis: case series.

artículo científico publicado en 2016

Diffusion MRI measured white matter microstructure as a biomarker of neurodegeneration in preclinical Huntington's disease

artículo científico publicado en 2013

Drug-induced movement disorders

artículo científico publicado en 2015

Effect of MPTP on mRNA expression of PGC-1α in mouse brain.

artículo científico publicado en 2017

Effect of subthalamic stimulation on distal and proximal upper limb movements in Parkinson's disease.

artículo científico publicado en 2016

Effects of mitochondrial toxins on the brain amino acid concentrations

artículo científico publicado en 2005

Effects of valproate on the dopaminergic system in mice

artículo científico publicado en 2008

Electron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi's Concept (Szeged) till Novel Approaches to Boost Mitochondrial Bioenergetics

artículo científico publicado en 2015

Elevated levels of PPAR-gamma in the cerebrospinal fluid of patients with multiple sclerosis

artículo científico publicado en 2013

Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines

scientific article published on April 2011

Epidemiology of multiple sclerosis in Central Europe, update from Hungary

scientific article published on 20 March 2020

Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severity.

artículo científico publicado en 2013

Genetic analysis of the SOD1 and C9ORF72 genes in Hungarian patients with amyotrophic lateral sclerosis.

artículo científico publicado en 2017

Genetic background of the hereditary spastic paraplegia phenotypes in Hungary - An analysis of 58 probands

artículo científico publicado en 2016

Glutamatergic dysfunctioning in Alzheimer's disease and related therapeutic targets.

artículo científico publicado en 2014

High-dose 1,25-dihydroxyvitamin D supplementation elongates the lifespan of Huntington's disease transgenic mice

artículo científico publicado en 2016

High-throughput sequencing revealed a novel SETX mutation in a Hungarian patient with amyotrophic lateral sclerosis.

artículo científico publicado en 2017

Histopathological comparison of Kearns-Sayre syndrome and PGC-1α-deficient mice suggests a novel concept for vacuole formation in mitochondrial encephalopathy

Increased glucose metabolism and ATP level in brain tissue of Huntington's disease transgenic mice

artículo científico publicado en 2008

Increased survival and neuroprotective effects of BN82451 in a transgenic mouse model of Huntington's disease.

artículo científico publicado en 2003

Independent validation of Parkinson’s disease Sleep Scale 2nd version (PDSS-2)

scholarly article by Norbert Kovács et al published 1 December 2015 in Sleep and Biological Rhythm

Indoleamine 2,3-dioxygenase as a novel therapeutic target for Huntington's disease

scientific article published on 22 November 2018

Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity

article

Inhibitors of the kynurenine pathway as neurotherapeutics: a patent review (2012-2015).

artículo científico publicado en 2016

Investigation of vitamin D receptor polymorphisms in amyotrophic lateral sclerosis.

artículo científico publicado en 2015

Is the MDS-UPDRS a Good Screening Tool for Detecting Sleep Problems and Daytime Sleepiness in Parkinson's Disease?

artículo científico publicado en 2014

Kynurenine metabolism in multiple sclerosis.

artículo científico publicado en 2005

Kynurenine metabolism in plasma and in red blood cells in Parkinson's disease

artículo científico publicado en 2005

Kynurenines in Parkinson's disease: therapeutic perspectives.

artículo científico publicado en 2011

Kynurenines in neurodegenerative disorders: therapeutic consideration.

artículo científico publicado en 2004

Lack of age-related clinical progression in PGC-1α-deficient mice - implications for mitochondrial encephalopathies

artículo científico publicado en 2016

Language deficits in pre-symptomatic Huntington's disease: evidence from Hungarian.

artículo científico publicado en 2012

Levodopa/carbidopa intestinal gel can improve both motor and non-motor experiences of daily living in Parkinson's disease: An open-label study

scientific article published on 03 February 2017

Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner.

artículo científico publicado en 2015

Malonate and 3-nitropropionic acid neurotoxicity are reduced in transgenic mice expressing a caspase-1 dominant-negative mutant.

artículo científico publicado en 2000

Manganese superoxide dismutase overexpression attenuates MPTP toxicity.

artículo científico publicado en 1998

Manipulating Kynurenic Acid Levels in the Brain – On the Edge Between Neuroprotection and Cognitive Dysfunction

Manipulating kynurenic acid levels in the brain - on the edge between neuroprotection and cognitive dysfunction.

artículo científico publicado en 2012

Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropropionic acid neurotoxicity

scientific journal article

Mice lacking alpha-synuclein are resistant to mitochondrial toxins

scientific journal article

Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: Novel therapeutic strategies for neurodegenerative disorders

artículo científico publicado en 2012

Mitochondrial disturbances, tryptophan metabolites and neurodegeneration: medicinal chemistry aspects.

artículo científico

N-acetyl-L-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis

article

Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice.

artículo científico publicado en 2003

Neurocognitive Characterization of an SCA28 Family Caused by a Novel AFG3L2 Gene Mutation

artículo científico publicado en 2017

Neuroimaging and cognitive changes during déjà vu.

artículo científico publicado en 2008

Neuropathology of partial PGC-1α deficiency recapitulates features of mitochondrial encephalopathies but not of neurodegenerative diseases.

artículo científico publicado en 2013

Neuroprotection in Parkinson's disease and other neurodegenerative disorders: preclinical and clinical findings

artículo científico publicado en 2009

Neuroprotective effects of L-carnitine in a transgenic animal model of Huntington's disease.

artículo científico publicado en 2009

Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington's disease.

artículo científico publicado en 2010

Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.

artículo científico publicado en 1999

Neuroprotective effects of oral administration of triacetyluridine against MPTP neurotoxicity

artículo científico publicado en 2004

Neuroprotective effects of phenylbutyrate against MPTP neurotoxicity.

artículo científico publicado en 2004

Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease

artículo científico publicado en 2004

Neuroprotective effects of probenecid in a transgenic animal model of Huntington's disease.

artículo científico publicado en 2009

Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase

artículo científico publicado en 2004

Non-motor Behavioral Alterations of PGC-1α-Deficient Mice - A Peculiar Phenotype With Slight Male Preponderance and No Apparent Progression

scientific article published on 27 August 2018

Nonenzymatic antioxidants of blood in multiple sclerosis

scientific article published on 01 July 1999

Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice.

artículo científico publicado en 2000

Novel AARS2 gene mutation producing leukodystrophy: a case report

artículo científico publicado en 2016

Novel free radical spin traps protect against malonate and MPTP neurotoxicity.

artículo científico publicado en 1999

Novel therapeutic strategies in Parkinson's disease.

artículo científico publicado en 2009

Opicapone for the treatment of Parkinson's disease: an update

artículo científico publicado en 2019

Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis

article

Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis

artículo científico publicado en 2000

Pediatric multiple sclerosis and fulminant disease course: Features and approaches to treatment - A case report and review of the literature

artículo científico publicado en 2018

Peripheral kynurenine metabolism in focal dystonia

artículo científico publicado en 2007

Pharmacological Models of Parkinson’s Disease in Rodents

scholarly article by Peter Klivenyi et al published 2011 in Methods in Molecular Biology

Postnatal outcome and placental blood flow after plasmapheresis during pregnancy.

artículo científico publicado en 2016

Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages: focus on cerebral amyloid angiopathy

artículo científico publicado en 2020

Predominant neurological phenotype in a Hungarian family with two novel mutations in the XPA gene-case series

scientific article published on 02 September 2019

Relevance of defensin β-2 and α defensins (HNP1-3) in Alzheimer's disease

artículo científico publicado en 2016

Selecting dopamine depleters for hyperkinetic movement disorders: how do we choose?

scientific article published on 30 October 2019

Somatostatin and Alzheimer's disease.

artículo científico publicado en 1995

Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson's disease.

artículo científico publicado en 2012

Synthesis and biological effects of some kynurenic acid analogs

artículo científico publicado en 2011

Target identification for stereotactic thalamotomy using diffusion tractography.

artículo científico publicado en 2012

Targeting the kynurenine pathway-related alterations in Alzheimer's disease: a future therapeutic strategy.

scientific article published on January 2011

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

artículo científico publicado en 2011

The Genetic Link between Parkinson's Disease and the Kynurenine Pathway Is Still Missing.

artículo científico publicado en 2015

The Report of p.Val717Phe Mutation in the APP Gene in a Hungarian Family With Alzheimer Disease: A Phenomenological Study.

artículo científico publicado en 2017

The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer's Disease: Shortcomings in Prodromal Diagnosis.

artículo científico publicado en 2016

The clinical manifestations of two novel SPAST mutations

artículo científico publicado en 2015

The detection of age-, gender-, and region-specific changes in mouse brain tocopherol levels via the application of different validated HPLC methods

artículo científico publicado en 2018

The effect of physical stimuli on the expression level of key elements in mitochondrial biogenesis

artículo científico publicado en 2019

The establishment of tocopherol reference intervals for Hungarian adult population using a validated HPLC method.

artículo científico publicado en 2017

The first identified Central-Eastern European patient with genetically confirmed dentatorubral-pallidoluysian atrophy

artículo científico publicado en 2015

The prevalence of multiple sclerosis in the Hungarian city of Szeged.

artículo científico publicado en 1998

The role of cognitive training in the neurorehabilitation of a patient who survived a lightning strike. A case study.

artículo científico publicado en 2014

The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection

artículo científico publicado en 2009

The rs13388259 Intergenic Polymorphism in the Genomic Context of the BCYRN1 Gene Is Associated with Parkinson's Disease in the Hungarian Population.

artículo científico publicado en 2018

The use of Stalevo in Hungary for patients with Parkinson disease and its effect on the quality of life

artículo científico publicado en 2008

Time-course of kynurenic acid concentration in mouse serum following the administration of a novel kynurenic acid analog

artículo científico publicado en 2011

Transgenic ALS mice show increased vulnerability to the mitochondrial toxins MPTP and 3-nitropropionic acid.

artículo científico publicado en 2001

Unilateral thalamic infarction causing downward gaze palsy in a patient with uncorrected tetralogy of Fallot: a case report = A lefelé tekintés bénulását okozó egyoldali thalamusinfarktus Fallot-tetralógia nem korrigált formájával élő fel

artículo científico publicado en 2016

Unlike PPARgamma, neither other PPARs nor PGC-1alpha is elevated in the cerebrospinal fluid of patients with multiple sclerosis.

artículo científico publicado en 2017

VALIDATION OF THE HUNGARIAN MDS-UPDRS: WHY DO WE NEED A NEW PARKINSON SCALE?

artículo científico publicado en 2014

Validation of the Hungarian Unified Dyskinesia Rating Scale

artículo científico publicado en 2015

Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease.

artículo científico publicado en 2009

[Clinical features and diagnosis of spinocerebellar ataxia]

artículo científico publicado en 2004

[Experience with levodopa/carbidopa intestinal gel in the treatment of advanced Parkinson's disease in Hungary].

artículo científico publicado en 2014

[GENETICALLY DETERMINED DISEASES ASSOCIATED WITH PATHOLOGICAL BRAIN IRON ACCUMULATION AND NEURODEGENERATION].

artículo científico publicado en 2016

[Long term experience with Stalevo in Szeged, Hungary].

artículo científico publicado en 2009

[Paroxysmal kinesigenic dyskinesia]

artículo científico publicado en 2011

[Recommendation for treatment options in advanced Parkinson's disease].

artículo científico publicado en 2016

[The absence of the common LRRK2 G2019S mutation in 120 young onset Hungarian Parkinon's disease patients]

scientific article published on 01 July 2012

[The treatment of advanced Parkinson's disease]

artículo científico publicado en 2018

[Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease]

scientific article published on 01 January 2007

alpha-Tocopherol/lipid ratio in blood is decreased in patients with Leber's hereditary optic neuropathy and asymptomatic carriers of the 11778 mtDNA mutation

artículo científico publicado en 2001

cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases

artículo científico publicado en 2010

mRNA expression levels of PGC-1α in a transgenic and a toxin model of Huntington's disease.

artículo científico publicado en 2014

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

artículo científico publicado en 2018

Lista de obras de Peter Klivenyi

24-Hour Near-Infrared Spectroscopy Monitoring of Acute Ischaemic Stroke Patients Undergoing Thrombolysis or Thrombectomy: A Pilot Study

A new myelin protein, TPPP/p25, reduced in demyelinated lesions is enriched in cerebrospinal fluid of multiple sclerosis

A novel SETX gene mutation producing ataxia with oculomotor apraxia type 2.

Additive neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.

Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis

Alpha-tocopherol and NADPH in the erythrocytes and plasma of multiple sclerosis patients. Effect of interferon-beta-1b treatment

Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines.

Amino acid concentrations in cerebrospinal fluid of patients with multiple sclerosis

Amino acids in the saliva of patients with migraine

An assessment of the frequency of mutations in the GBA and VPS35 genes in Hungarian patients with sporadic Parkinson’s disease

Angiogenin mutations in Hungarian patients with amyotrophic lateral sclerosis: Clinical, genetic, computational, and functional analyses.

Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients

Assessment of the role of multidrug resistance-associated proteins in MPTP neurotoxicity in mice

Association of vitamin D receptor gene polymorphisms and Parkinson's disease in Hungarians.

Azulenyl nitrone spin traps protect against MPTP neurotoxicity.

B7 costimulation and intracellular indoleamine-2,3-dioxygenase (IDO) expression in peripheral blood of healthy pregnant and non-pregnant women.

Behaviour changes in a transgenic model of Huntington's disease.

Central nervous system-specific alterations in the tryptophan metabolism in the 3-nitropropionic acid model of Huntington's disease

Clinical studies on pramipexol retard

Clinical studies with levodopa/carbidopa intestinal gel

Clinicopathological Relationships in an Aged Case of DOORS Syndrome With a p.Arg506X Mutation in the ATP6V1B2 Gene

Cognitive functions in ataxia with oculomotor apraxia type 2.

Different phenotypes in identical twins with cerebrotendinous xanthomatosis: case series.

Diffusion MRI measured white matter microstructure as a biomarker of neurodegeneration in preclinical Huntington's disease

Drug-induced movement disorders

Effect of MPTP on mRNA expression of PGC-1α in mouse brain.

Effect of subthalamic stimulation on distal and proximal upper limb movements in Parkinson's disease.

Effects of mitochondrial toxins on the brain amino acid concentrations

Effects of valproate on the dopaminergic system in mice

Electron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi's Concept (Szeged) till Novel Approaches to Boost Mitochondrial Bioenergetics

Elevated levels of PPAR-gamma in the cerebrospinal fluid of patients with multiple sclerosis

Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines

Epidemiology of multiple sclerosis in Central Europe, update from Hungary

Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severity.

Genetic analysis of the SOD1 and C9ORF72 genes in Hungarian patients with amyotrophic lateral sclerosis.

Genetic background of the hereditary spastic paraplegia phenotypes in Hungary - An analysis of 58 probands

Glutamatergic dysfunctioning in Alzheimer's disease and related therapeutic targets.

High-dose 1,25-dihydroxyvitamin D supplementation elongates the lifespan of Huntington's disease transgenic mice

High-throughput sequencing revealed a novel SETX mutation in a Hungarian patient with amyotrophic lateral sclerosis.

Histopathological comparison of Kearns-Sayre syndrome and PGC-1α-deficient mice suggests a novel concept for vacuole formation in mitochondrial encephalopathy

Increased glucose metabolism and ATP level in brain tissue of Huntington's disease transgenic mice

Increased survival and neuroprotective effects of BN82451 in a transgenic mouse model of Huntington's disease.

Independent validation of Parkinson’s disease Sleep Scale 2nd version (PDSS-2)

Indoleamine 2,3-dioxygenase as a novel therapeutic target for Huntington's disease

Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity

Inhibitors of the kynurenine pathway as neurotherapeutics: a patent review (2012-2015).

Investigation of vitamin D receptor polymorphisms in amyotrophic lateral sclerosis.

Is the MDS-UPDRS a Good Screening Tool for Detecting Sleep Problems and Daytime Sleepiness in Parkinson's Disease?

Kynurenine metabolism in multiple sclerosis.

Kynurenine metabolism in plasma and in red blood cells in Parkinson's disease

Kynurenines in Parkinson's disease: therapeutic perspectives.

Kynurenines in neurodegenerative disorders: therapeutic consideration.

Lack of age-related clinical progression in PGC-1α-deficient mice - implications for mitochondrial encephalopathies

Language deficits in pre-symptomatic Huntington's disease: evidence from Hungarian.

Levodopa/carbidopa intestinal gel can improve both motor and non-motor experiences of daily living in Parkinson's disease: An open-label study

Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner.

Malonate and 3-nitropropionic acid neurotoxicity are reduced in transgenic mice expressing a caspase-1 dominant-negative mutant.

Manganese superoxide dismutase overexpression attenuates MPTP toxicity.

Manipulating Kynurenic Acid Levels in the Brain – On the Edge Between Neuroprotection and Cognitive Dysfunction

Manipulating kynurenic acid levels in the brain - on the edge between neuroprotection and cognitive dysfunction.

Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropropionic acid neurotoxicity

Mice lacking alpha-synuclein are resistant to mitochondrial toxins

Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: Novel therapeutic strategies for neurodegenerative disorders

Mitochondrial disturbances, tryptophan metabolites and neurodegeneration: medicinal chemistry aspects.

N-acetyl-L-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis

Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice.

Neurocognitive Characterization of an SCA28 Family Caused by a Novel AFG3L2 Gene Mutation

Neuroimaging and cognitive changes during déjà vu.

Neuropathology of partial PGC-1α deficiency recapitulates features of mitochondrial encephalopathies but not of neurodegenerative diseases.

Neuroprotection in Parkinson's disease and other neurodegenerative disorders: preclinical and clinical findings

Neuroprotective effects of L-carnitine in a transgenic animal model of Huntington's disease.

Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington's disease.

Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.

Neuroprotective effects of oral administration of triacetyluridine against MPTP neurotoxicity

Neuroprotective effects of phenylbutyrate against MPTP neurotoxicity.

Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease

Neuroprotective effects of probenecid in a transgenic animal model of Huntington's disease.

Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase

Non-motor Behavioral Alterations of PGC-1α-Deficient Mice - A Peculiar Phenotype With Slight Male Preponderance and No Apparent Progression